These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 24403051)

  • 61. DNA copy number alterations, gene expression changes and disease-free survival in patients with colorectal cancer: a 10 year follow-up.
    Bigagli E; De Filippo C; Castagnini C; Toti S; Acquadro F; Giudici F; Fazi M; Dolara P; Messerini L; Tonelli F; Luceri C
    Cell Oncol (Dordr); 2016 Dec; 39(6):545-558. PubMed ID: 27709558
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Immunohistochemical analysis of the p53 tumor suppressor gene product in oral leukoplakia].
    Kikegawa A
    Kokubyo Gakkai Zasshi; 2001 Mar; 68(1):51-9. PubMed ID: 11321806
    [TBL] [Abstract][Full Text] [Related]  

  • 63. DeltaNp63 overexpression, alone and in combination with other biomarkers, predicts the development of oral cancer in patients with leukoplakia.
    Saintigny P; El-Naggar AK; Papadimitrakopoulou V; Ren H; Fan YH; Feng L; Lee JJ; Kim ES; Hong WK; Lippman SM; Mao L
    Clin Cancer Res; 2009 Oct; 15(19):6284-91. PubMed ID: 19773378
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Secretory leukocyte peptidase inhibitor expression and apoptosis effect in oral leukoplakia and oral squamous cell carcinoma.
    Wang X; Jin Y; Li YX; Yang Y
    Oncol Rep; 2018 Apr; 39(4):1793-1804. PubMed ID: 29436667
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Mutated and wild-type p53 expression and HPV integration in proliferative verrucous leukoplakia and oral squamous cell carcinoma.
    Gopalakrishnan R; Weghorst CM; Lehman TA; Calvert RJ; Bijur G; Sabourin CL; Mallery SR; Schuller DE; Stoner GD
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1997 Apr; 83(4):471-7. PubMed ID: 9127380
    [TBL] [Abstract][Full Text] [Related]  

  • 66. LAMC2 is a predictive marker for the malignant progression of leukoplakia.
    Nguyen CT; Okamura T; Morita KI; Yamaguchi S; Harada H; Miki Y; Izumo T; Kayamori K; Yamaguchi A; Sakamoto K
    J Oral Pathol Med; 2017 Mar; 46(3):223-231. PubMed ID: 27529842
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Determination and diagnostic value of CA9 mRNA in peripheral blood of patients with oral leukoplakia.
    Torres López M; Pérez Sayáns M; Chamorro Petronacci C; Barros Angueira F; Gándara Vila P; Lorenzo Pouso A; García García A
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):951-955. PubMed ID: 29745265
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Application of a non-invasive oral brushing procedure based on bisulfite sequencing of a 13-gene panel to study high-risk OSCC patients.
    Gissi DB; Gabusi A; Tarsitano A; Asioli S; Rossi R; Marchetti C; Montebugnoli L; Foschini MP; Morandi L
    Cancer Biomark; 2020; 28(4):499-510. PubMed ID: 32568174
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Oral squamous cell carcinomas are characterized by a rather uniform pattern of genomic imbalances detected by comparative genomic hybridisation.
    Wolff E; Girod S; Liehr T; Vorderwülbecke U; Ries J; Steininger H; Gebhart E
    Oral Oncol; 1998 May; 34(3):186-90. PubMed ID: 9692052
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Progress risk assessment of oral premalignant lesions with saliva miRNA analysis.
    Yang Y; Li YX; Yang X; Jiang L; Zhou ZJ; Zhu YQ
    BMC Cancer; 2013 Mar; 13():129. PubMed ID: 23510112
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Analysis of molecular cytogenetic alterations in uterine leiomyosarcoma by array-based comparative genomic hybridization.
    Raish M; Khurshid M; Ansari MA; Chaturvedi PK; Bae SM; Kim JH; Park EK; Park DC; Ahn WS
    J Cancer Res Clin Oncol; 2012 Jul; 138(7):1173-86. PubMed ID: 22419440
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Amplification of EMS1 gene in oral carcinogenesis].
    Xia J; Li BQ; Zeng X; Chen QM; He Y; Cai Y
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2005 Mar; 40(2):102-4. PubMed ID: 15842855
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Role of TP53 in the progression of pre-malignant and malignant oral mucosal lesions. A follow-up study of 144 patients.
    Ogmundsdóttir HM; Björnsson J; Holbrook WP
    J Oral Pathol Med; 2009 Aug; 38(7):565-71. PubMed ID: 19473450
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Patterns of chromosomal copy-number alterations in intrahepatic cholangiocarcinoma.
    Dalmasso C; Carpentier W; Guettier C; Camilleri-Broët S; Borelli WV; Campos Dos Santos CR; Castaing D; Duclos-Vallée JC; Broët P
    BMC Cancer; 2015 Mar; 15():126. PubMed ID: 25879652
    [TBL] [Abstract][Full Text] [Related]  

  • 75. OCGR array: an oral cancer genomic regional array for comparative genomic hybridization analysis.
    Garnis C; Campbell J; Zhang L; Rosin MP; Lam WL
    Oral Oncol; 2004 May; 40(5):511-9. PubMed ID: 15006624
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Chromosomal Alterations and Gene Expression Changes Associated with the Progression of Leukoplakia to Advanced Gingivobuccal Cancer.
    Bhosale PG; Cristea S; Ambatipudi S; Desai RS; Kumar R; Patil A; Kane S; Borges AM; Schäffer AA; Beerenwinkel N; Mahimkar MB
    Transl Oncol; 2017 Jun; 10(3):396-409. PubMed ID: 28433800
    [TBL] [Abstract][Full Text] [Related]  

  • 77. ATM in oral carcinogenesis: association with clinicopathological features.
    He Y; Chen Q; Li B
    J Cancer Res Clin Oncol; 2008 Sep; 134(9):1013-20. PubMed ID: 18288488
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Salivary proteins from dysplastic leukoplakia and oral squamous cell carcinoma and their potential for early detection.
    Sivadasan P; Gupta MK; Sathe G; Sudheendra HV; Sunny SP; Renu D; Hari PS; Gowda H; Suresh A; Kuriakose MA; Sirdeshmukh R
    J Proteomics; 2020 Feb; 212():103574. PubMed ID: 31706945
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Determination of human papillomavirus in oral leukoplakia,oral lichen planus and oral squamous cell carcinoma].
    Cao J; Jin JQ; Deng DJ; Liu HW
    Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Feb; 48(1):84-8. PubMed ID: 26885914
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Genomic landscape of pancreatic neuroendocrine tumors.
    Gebauer N; Schmidt-Werthern C; Bernard V; Feller AC; Keck T; Begum N; Rades D; Lehnert H; Brabant G; Thorns C
    World J Gastroenterol; 2014 Dec; 20(46):17498-506. PubMed ID: 25516664
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.